Advertisement
Advertisement
U.S. markets closed
Advertisement
Advertisement
Advertisement
Advertisement

Parnell Pharmaceuticals Holdings Ltd (PARNF)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.00020.0000 (0.00%)
At close: 09:30AM EST
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close0.0002
Open0.0002
BidN/A x N/A
AskN/A x N/A
Day's Range0.0002 - 0.0002
52 Week Range0.0001 - 0.8900
Volume100
Avg. Volume1,113
Market Cap2.867M
Beta (5Y Monthly)5.11
PE Ratio (TTM)N/A
EPS (TTM)-0.2880
Earnings DateApr 04, 2020 - Apr 08, 2020
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
N/A

Subscribe to Yahoo Finance Plus to view Fair Value for PARNF

Learn more
View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • PARNELL PHARMACEUTICALS HLDGS L
    Daily – Vickers Top Insider Picks for 01/13/2022The Vickers Top Insider Picks is a daily report that utilizes a proprietary algorithm to identify 25 companies with compelling insider purchase histories based on transactions over the past three months.
    Rating
    Fair Value
    Economic Moat
    9 days agoArgus Research
View more
  • ACCESSWIRE

    Parnell Pharmaceuticals Gives Notice of Annual General Meeting and Explanatory Memorandum

    SYDNEY, AUSTRALIA / ACCESSWIRE / July 14, 2021 / Parnell Pharmaceuticals Holdings Ltd (OTC PINK:PARNF), a fully integrated, commercial-stage pharmaceutical company focused on developing, manufacturing and marketing innovative animal health solutions, provides notice of its Annual General Meeting to be held Thursday, 5th August 2021 at 8:30 a. (Australian Eastern Standard Time)NOTICE OF ANNUAL GENERAL MEETING AND EXPLANATORY MEMORANDUMNotice is given that the Annual General Meeting of shareholder

  • PR Newswire

    DW Healthcare Partners Invests in Parnell

    DW Healthcare Partners ("DWHP") a healthcare-focused private equity firm, announced the completion of its investment in Parnell Pharmaceuticals Holdings Ltd (OTC: PARNF) ("Parnell" or the "Company"). Founded over 50 years ago in Australia, Parnell is a fully integrated manufacturer and developer of animal health pharmaceuticals focused on the US market.

  • PR Newswire

    DWHP Announces Expiration And Final Results Of Its Cash Tender Offer For All Outstanding Ordinary Shares Of Parnell Pharmaceuticals Holdings Ltd.

    DW Healthcare Partners V, L.P. ("DWHP"), announced today the expiration and final results of its previously announced cash tender offer (the "Tender Offer") to purchase all of the outstanding ordinary shares (the "Tender Securities") of Parnell Pharmaceuticals Holdings Ltd (OTC Pink Open Market: PARNF) ("Parnell") at a price of U.S.$0.40 per share, net to the seller in cash without interest and less applicable withholding taxes. The Tender Offer expired at one minute after 11:59 p.m., New York City time on January 28, 2021 (the "Expiration Time").

Advertisement
Advertisement